SCHEMBL4917847

SCHEMBL4917847

Cc1ccc(C(O)=S)c(-c2ccccc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 1/20 0.43
SYK P43405 1/20 0.41
AURKB Q96GD4 1/20 0.41
INCENP Q9NQS7 1/20 0.41
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 4/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 1/20 0.38
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
MAPK1 P28482 1/20 0.37
ATM Q13315 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
PDE10A Q9Y233 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
POLB P06746 1/20 0.37
PKM P14618 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5532405 0.81 ALDH1A1 (0.54) NTRK1ALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL29002505 0.79 KDM4E (0.53) NTRK1ALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL4917844 0.79 NTRK1 (0.45) NTRK1SYKAURKBINCENPALDH1A1
SCHEMBL20124614 0.75 ALDH1A1 (0.49) NTRK1SYKAURKBINCENPTDP1
SCHEMBL11733981 0.74 PDE10A (0.52) NTRK1SYKAURKBINCENPTDP1
SCHEMBL5360517 0.72 SYK (0.45) NTRK1SYKAURKBINCENPTDP1
SCHEMBL15716526 0.71 ADORA2A (0.49) SYKAURKBINCENPTDP1ALDH1A1
SCHEMBL30573063 0.71 ADORA1 (0.49) NTRK1SYKAURKBINCENPTDP1
SCHEMBL26606982 0.71 ADORA1 (0.49) NTRK1SYKAURKBINCENPTDP1
SCHEMBL28329598 0.70 ALDH1A1 (0.41) TDP1ALDH1A1KDM4ESMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1885817-B1 RESPONSIVE LUMINESCENT LANTHANIDE COMPLEXES UNIV DURHAM (GB) 2016-05-11 EP disclosed
US-8193174-B2 Responsive luminescent lanthanide complexes UNIVERSITY OF DURHAM (GB) 2012-06-05 US disclosed
US-20080312431-A1 Responsive Luminescent Lanthanide Complexes UNIVERSITY OF DURHAM (GB) 2008-12-18 US disclosed
EP-1885817-A1 RESPONSIVE LUMINESCENT LANTHANIDE COMPLEXES UNIVERSITY OF DURHAM (GB) 2008-02-13 EP disclosed
WO-2006120444-A1 RESPONSIVE LUMINESCENT LANTHANIDE COMPLEXES UNIVERSITY OF DURHAM (GB) 2006-11-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312431-A1 Responsive Luminescent Lanthanide Complexes TPR, NLRP1, NISCH NTRK1 171/4885SYK 3553/4885AURKB 2391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.